IR@PKUHSC  > 北京大学第一临床医学院  > 药剂科
学科主题药剂学
地塞米松棕榈酸酯注射液在中国健康受试者的药代动力学研究
其他题名Pharmacokinetic study of dexamethasone palmitate injection in Chinese healthy volunteers
梁雁; 许俊羽; 赵侠; 周颖; 孙培红; 张慧琳; 崔一民
关键词地塞米松棕榈酸酯注射液 药代动力学 液相色谱-串联质谱 Dexamethasone Palmitate Injection Pharmacokinetic Lc-ms/ms
刊名中国临床药理学杂志
2015
DOI10.13699/j.cnki.1001-6821.2015.16.017
16页:1613-1617
收录类别中国科技核心期刊 ; 中文核心期刊 ; CSCD
文章类型Journal Article
摘要目的:研究健康受试者单剂量静脉注射两种地塞米松棕榈酸酯的药代动力学。方法用开放、双周期随机交叉给药方案,10名健康受试者单剂量静脉注射两种地塞米松棕榈酸酯1 mL,用LC-MS/MS法测定血浆中地塞米松棕榈酸酯、地塞米松和尿样中的地塞米松,计算其主要药代动力学参数。结果9名受试者完成全部试验。单剂量静脉注射地塞米松棕榈酸酯受试制剂和参比制剂后,地塞米松棕榈酸酯的主要药代动力学参数:AUC0-tn分别为(951.57±341.39),(955.03±434.42) ng ? mL-1? h;AUC0-∞分别为(954.83±341.82),(957.85±433.95)ng? mL-1? h;cmax分别为(681.33±307.91),(622.00±205.71) ng? mL-1;t1/2分别为(0.73±0.05),(0.76±0.18)h。单剂量静脉注射地塞米松棕榈酸酯受试制剂和参比制剂后,地塞米松的主要药代动力学参数:AUC0-tn分别为(179.11±27.99),(199.18±26.90) ng? mL-1? h;AUC0-∞分别为(208.35±37.54),(237.45±45.52) ng? mL-1? h;cmax分别为(26.17±3.19),(32.44±2.74) ng? mL-1;tmax分别为(2.00±1.09),(1.56±0.64) h,t1/2分别为(3.74±1.02),(4.30±1.46)h。48 h地塞米松的尿中累积排泄率分别为(3.58±1.07)%和(3.93±1.23)%。结论两种制剂的主要药代动力学参数无显著性差异。 Objective To study the pharmacokinetics of dexamethasone palmitate injection in Chinese healthy volunteers.Methods A single administration of 1 mL dexamethasone palmitate injection of test and reference formulation was given to 10 healthy volunteers by intravenous injection according to an open, randomized, cross-over study.The con-centrations of dexamethasone palmitate and dexamethasone in plasma and urine were determined by LC-MS/MS method, the pharmacokinetic pa-rameters were calculated.Results Nine healthy volunteers had comple-ted the full clinical trail.The main pharmacokinetic parameters of dexa-methasone palmitate were as follows.AUC0-tn were (951.57 ±341.39), (955.03 ±434.42)ng? mL-1? h, AUC0-∞ were(954.83 ±341.82), (957.85 ±433.95 ) ng? mL-1? h, cmax were ( 681.33 ±307.91 ) , ( 622.00 ± 205.71 ) ng ? mL-1 , t1/2 were ( 0.73 ± 0.05 ) , (0.76 ±0.18)h for test and reference formulation, respectively.The main pharmacokinetic parameters of dexamethasone were as follows. AUC0-tn were ( 179.11 ±27.99 ) , ( 199.18 ±26.90 ) ng? mL-1? h, AUC0-∞ were(208.35 ±37.54), (237.45 ±45.52) ng? mL-1? h, cmax were (26.17 ±3.19), (32.44 ±2.74) ng? mL-1, tmax were(2.00 ±1.09), (1.56 ±0.64)h, t1/2 were(3.74 ±1.02), (4.30 ±1.46)h for test and refer-ence formulation, respectively. Cumulative 48 h urine excretion accounted for ( 3.58 ± 1.07 )% and (3.93 ±1.23)%, respectively.Conclusion There is no significant difference between the main pharmacokinetic parameters of two formulations of dexamethasone palmitate injection.
语种中文
原文出处查看原文
引用统计
文献类型期刊论文
条目标识符http://ir.bjmu.edu.cn/handle/400002259/43839
专题北京大学第一临床医学院_药剂科
作者单位北京大学第一医院药剂科,北京,100034
推荐引用方式
GB/T 7714
梁雁,许俊羽,赵侠,等. 地塞米松棕榈酸酯注射液在中国健康受试者的药代动力学研究[J]. 中国临床药理学杂志,2015(16):1613-1617.
APA 梁雁.,许俊羽.,赵侠.,周颖.,孙培红.,...&崔一民.(2015).地塞米松棕榈酸酯注射液在中国健康受试者的药代动力学研究.中国临床药理学杂志(16),1613-1617.
MLA 梁雁,et al."地塞米松棕榈酸酯注射液在中国健康受试者的药代动力学研究".中国临床药理学杂志 .16(2015):1613-1617.
条目包含的文件
条目无相关文件。
个性服务
推荐该条目
保存到收藏夹
查看访问统计
导出为Endnote文件
谷歌学术
谷歌学术中相似的文章
[梁雁]的文章
[许俊羽]的文章
[赵侠]的文章
百度学术
百度学术中相似的文章
[梁雁]的文章
[许俊羽]的文章
[赵侠]的文章
必应学术
必应学术中相似的文章
[梁雁]的文章
[许俊羽]的文章
[赵侠]的文章
相关权益政策
暂无数据
收藏/分享
所有评论 (0)
暂无评论
 

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。